Background: : Prediction of mode of death (sudden cardiac death (SCD) and pump failure death (PFD)) in patients with chronic heart failure (CHF) may facilitate decisions about specific medications or devices. Cardiac I-123 metaiodobenzylguanidine (MIBG) imaging provides prognostic information in patients with CHF. On the other hand, fragmented QRS complexes (fQRS) on the 12-lead ECG have been associated with poor outcome in CHF patients. However, there is no information available on the comparison of the prognostic value about mode of death between MIBG imaging and fQRS in CHF patients.
